Utility of transesophageal echocardiography in identification of thrombogenic milieu in patients with atrial fibrillation (an ACUTE Ancillary Study)

American Journal of Cardiology

Volumn 96, Issue 7, 2005, Pages 935-941

  Thambidorai, Senthil K ^a   Murray, R Daniel ^a   Parakh, Kapil ^a   Shah, Tushar K ^a   Black, Ian W ^b   Jasper, Susan E ^a   Li, Jianbo ^a   Apperson Hansen, Carolyn ^a   Asher, Craig R ^a   Grimm, Richard A ^a   Klein, Allan L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b MANLY HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; CONTRAST MEDIUM; HEPARIN; WARFARIN;

ADULT; AGED; ANEURYSM; ANTICOAGULATION; AORTA ATHEROSCLEROSIS; ARTICLE; CARDIOVERSION; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM SEPTUM; HEART ATRIUM SEPTUM DEFECT; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE; PREDICTION; PRIORITY JOURNAL; RANDOMIZATION; RISK FACTOR; STATISTICAL SIGNIFICANCE; THROMBOEMBOLISM; THROMBOGENICITY; THROMBUS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ELECTRIC COUNTERSHOCK; FEMALE; HEART ATRIA; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS; THROMBOEMBOLISM; THROMBOSIS;

EID: 25444442635     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.05.051     Document Type: Article

References (30)

1. A.L. Klein, R.A. Grimm, R.D. Murray, C. Apperson-Hansen, R.W. Asinger, I.W. Black, R. Davidoff, R. Erbel, J.L. Halperin, D.A. Orsinelli Assessment of Cardioversion Using Transesophageal Echocardiography Investigators Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation N Engl J Med 344 2001 1411 1420
2. R.G. Hart, L.A. Pearce, R. McBride, R.M. Rothbart, R.W. Asinger Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators Stroke 30 1999 1223 1229
3. Atrial Fibrillation Investigators Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials Arch Intern Med 154 1994 1449 1457
4. B.F. Gage, A.D. Waterman, W. Shannon, M. Boechler, M.W. Rich, M.J. Radford Validation of clinical classification schemes for predicting stroke results from the National Registry of Atrial Fibrillation JAMA 285 2001 2864 2870
5. V. Fuster, L.E. Ryden, R.W. Asinger, D.S. Cannom, H.J. Crijns, R.L. Frye, J.L. Halperin, G.N. Kay, W.W. Klein, S. Levy American College of Cardiology, American Heart Association, European Society of Cardiology, North American Society of Pacing and Electrophysiology ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology Eur Heart J 22 2001 1852 1923
6. D.E. Singer, G.W. Albers, J.E. Dalen, A.S. Go, J.L. Halperin, W.J. Manning Antithrombotic therapy in atrial fibrillation the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 126 2004 429S 456S
7. The Stroke Prevention in Atrial Fibrillation Investigators Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk Ann Intern Med 116 1992 1 5
8. The Stroke Prevention in Atrial Fibrillation Investigators Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk Ann Intern Med 116 1992 6 12
9. M. Zabalgoitia, J.L. Halperin, L.A. Pearce, J.L. Blackshear, R.W. Asinger, R.G. Hart Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke Prevention in Atrial Fibrillation III Investigators J Am Coll Cardiol 31 1998 1622 1626
10. The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation Ann Intern Med 128 1998 639 647
11. W.J. Manning, D.I. Silverman, C.S. Keighley, P. Oettgen, P.S. Douglas Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation final results of a prospective 4.5-year study J Am Coll Cardiol 25 1995 1354 1361
12. M.F. Stoddard, P.R. Dawkins, C.R. Prince, R.A. Longaker Transesophageal echocardiographic guidance of cardioversion in patients with atrial fibrillation Am Heart J 129 1995 1204 1215
13. G. Corrado, M. Santarone, S. Beretta, G. Tadeo, L.M. Tagliagambe, G. Foglia-Manzillo, M. Spata, E. Miglierina, F. Acquati, M. Santarone Early cardioversion of atrial fibrillation and atrial flutter guided by transoesophageal echocardiography a single centre 8.5-year experience Europace 2 2000 119 126
14. A.L. Klein, R.D. Murray, R.A. Grimm Role of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation J Am Coll Cardiol 37 2001 691 704
15. L.M. Tsai, L.J. Lin, J.K. Teng, J.H. Chen Prevalence and clinical significance of left atrial thrombus in nonrheumatic atrial fibrillation Int J Cardiol 58 1997 163 169
16. G. Corrado, G. Tadeo, S. Beretta, L.M. Tagliagambe, G.F. Manzillo, M. Spata, M. Santarone Atrial thrombi resolution after prolonged anticoagulation in patients with atrial fibrillation Chest 115 1999 140 143
17. L.J. Collins, D.I. Silverman, P.S. Douglas, W.J. Manning Cardioversion of nonrheumatic atrial fibrillation. Reduced thromboembolic complications with 4 weeks of precardioversion anticoagulation are related to atrial thrombus resolution Circulation 92 1995 160 163
18. W.A. Jaber, D.L. Prior, M. Thamilarasan, R.A. Grimm, J.D. Thomas, A.L. Klein, C.R. Asher Efficacy of anticoagulation in resolving left atrial and left atrial appendage thrombi a transesophageal echocardiographic study Am Heart J 140 2000 150 156
19. Y. Abe, T. Asakura, J. Gotou, M. Iwai, Y. Watanabe, M. Sando, S. Ishikawa, K. Nagata, T. Saito, K. Maehara, Y. Maruyama Prediction of embolism in atrial fibrillation classification of left atrial thrombi by transesophageal echocardiography Jpn Circ J 64 2000 411 415
20. M.D. Ezekowitz, K.E. James, S.M. Nazarian, J. Davenport, J.P. Broderick, S.R. Gupta, V. Thadani, M.L. Meyer, S.L. Bridgers Silent cerebral infarction in patients with nonrheumatic atrial fibrillation. The Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators Circulation 92 1995 2178 2182
21. I.W. Black, A.P. Hopkins, L.C. Lee, W.F. Walsh Left atrial spontaneous echo contrast a clinical and echocardiographic analysis J Am Coll Cardiol 18 1991 398 404
22. P. Amarenco, A. Cohen, C. Tzourio, B. Bertrand, M. Hommel, G. Besson, C. Chauvel, P.J. Touboul, M.G. Bousser Atherosclerotic disease of the aortic arch and the risk of ischemic stroke N Engl J Med 331 1994 1474 1479
23. S. Homma, R.L. Sacco, M.R. Di Tullio, R.R. Sciacca, J.P. Mohr PFO in Cryptogenic Stroke Study (PICSS) Investigators Effect of medical treatment in stroke patients with patent foramen ovale Patent Foramen Ovale in Cryptogenic Stroke Study Circulation 105 2002 2625 2631
24. M. Zabalgoitia, L.P. Norris, M. Garcia Atrial septal aneurysm as a potential source of neurological ischemic events Am J Card Imaging 8 1994 39 44
25. L.R. Isada, J.N. Torelli, W.J. Stewart, A.L. Klein Detection of fibrous strands on prosthetic mitral valves with transesophageal echocardiography another potential embolic source J Am Soc Echocardiogr 7 1994 641 645
26. S. Illien, S. Maroto-Jarvinen, G. von der Recke, C. Hammerstingl, H. Schmidt, S. Kuntz-Hehner, B. Luderitz, H. Omran Atrial fibrillation relation between clinical risk factors and transoesophageal echocardiographic risk factors for thromboembolism Heart 89 2003 165 168
27. C. Stollberger, P. Chnupa, G. Kronik, M. Brainin, J. Finsterer, B. Schneider, J. Slany Transesophageal echocardiography to assess embolic risk in patients with atrial fibrillation. ELAT Study Group. Embolism in Left Atrial Thrombi Ann Intern Med 128 1998 630 638
28. A.C. Pearson, A.J. Labovitz, S. Tatineni, C.R. Gomez Superiority of transesophageal echocardiography in detecting cardiac source of emboli in patients with cerebral ischemia of uncertain etiology J Am Coll Cardiol 17 1991 66 72
29. T.B. Seto, D.A. Taira, J. Tsevat, W.J. Manning Cost-effectiveness of transesophageal echocardiographic-guided cardioversion a decision analytic model for patients admitted to the hospital with atrial fibrillation J Am Coll Cardiol 29 1997 122 130
30. A.L. Klein, R.D. Murray, E.R. Becker, S.D. Culler, W.S. Weintraub, S.E. Jasper, E.A. Lieber, C. Apperson-Hansen, A.M. Heerey, R.A. Grimm ACUTE Investigators Economic analysis of a transesophageal echocardiography-guided approach to cardioversion of patients with atrial fibrillation the ACUTE economic data at eight weeks J Am Coll Cardiol 43 2004 1217 1224